메뉴 건너뛰기




Volumn 20, Issue 19, 2014, Pages 5113-5123

Clinical implications of phosphorylated STAT3 expression in de Novo diffuse large B-cell lymphoma

(28)  Ok, Chi Young a   Chen, Jiayu b   Xu Monette, Zijun Y a   Tzankov, Alexandar c   Manyam, Ganiraju C a   Li, Ling a   Visco, Carlo d   Montes Moreno, Santiago e   Dybkær, Karen f   Chiu, April g   Orazi, Attilio h   Zu, Youli i   Bhagat, Govind j   Richards, Kristy L k   Hsi, Eric D l   Choi, William W L m   Van Krieken, J Han n   Huh, Jooryung o   Zhao, Xiaoying p   Ponzoni, Maurilio q   more..


Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; MESSENGER RNA; MYC PROTEIN; PROTEIN BCL 2; PROTEIN KINASE B; STAT3 PROTEIN; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCLONAL ANTIBODY; PREDNISONE; PROTEIN P53; R-CHOP PROTOCOL; VINCRISTINE;

EID: 84907651091     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-14-0683     Document Type: Article
Times cited : (64)

References (50)
  • 2
    • 84864517049 scopus 로고    scopus 로고
    • Diffuse large B-cell lymphoma: Current strategies and future directions
    • Cultrera JL, Dalia SM. Diffuse large B-cell lymphoma: current strategies and future directions. Cancer Control 2012;19:204-13.
    • (2012) Cancer Control , vol.19 , pp. 204-213
    • Cultrera, J.L.1    Dalia, S.M.2
  • 3
    • 0034598746 scopus 로고    scopus 로고
    • Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
    • Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-11.
    • (2000) Nature , vol.403 , pp. 503-511
    • Alizadeh, A.A.1    Eisen, M.B.2    Davis, R.E.3    Ma, C.4    Lossos, I.S.5    Rosenwald, A.6
  • 4
    • 24644500086 scopus 로고    scopus 로고
    • Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia
    • Sehn LH, Donaldson J, Chhanabhai M, Fitzgerald C, Gill K, Klasa R, et al. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol 2005;23:5027-33.
    • (2005) J Clin Oncol , vol.23 , pp. 5027-5033
    • Sehn, L.H.1    Donaldson, J.2    Chhanabhai, M.3    Fitzgerald, C.4    Gill, K.5    Klasa, R.6
  • 5
    • 84865865930 scopus 로고    scopus 로고
    • Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: A report from the International DLBCL Rituximab-CHOP Consortium Program Study
    • Visco C, Li Y, Xu-Monette ZY, Miranda RN, Green TM, Tzankov A, et al. Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. Leukemia 2012;26:2103-13.
    • (2012) Leukemia , vol.26 , pp. 2103-2113
    • Visco, C.1    Li, Y.2    Xu-Monette, Z.Y.3    Miranda, R.N.4    Green, T.M.5    Tzankov, A.6
  • 6
    • 0037443661 scopus 로고    scopus 로고
    • Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3
    • Niemand C, Nimmesgern A, Haan S, Fischer P, Schaper F, Rossaint R, et al. Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3. J Immunol 2003;170:3263-72.
    • (2003) J Immunol , vol.170 , pp. 3263-3272
    • Niemand, C.1    Nimmesgern, A.2    Haan, S.3    Fischer, P.4    Schaper, F.5    Rossaint, R.6
  • 7
    • 1042302005 scopus 로고    scopus 로고
    • The STATs of cancer - New molecular targets come of age
    • Yu H, Jove R. The STATs of cancer - new molecular targets come of age. Nat Rev Cancer 2004;4:97-105.
    • (2004) Nat Rev Cancer , vol.4 , pp. 97-105
    • Yu, H.1    Jove, R.2
  • 8
    • 0037327154 scopus 로고    scopus 로고
    • Regulation of Stat3 nuclear export
    • Bhattacharya S, Schindler C. Regulation of Stat3 nuclear export. J Clin Invest 2003;111:553-9.
    • (2003) J Clin Invest , vol.111 , pp. 553-559
    • Bhattacharya, S.1    Schindler, C.2
  • 9
    • 0029117304 scopus 로고
    • Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation
    • Wen Z, Zhong Z, Darnell JE Jr. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 1995;82:241-50.
    • (1995) Cell , vol.82 , pp. 241-250
    • Wen, Z.1    Zhong, Z.2    Darnell, J.E.3
  • 10
    • 15744385061 scopus 로고    scopus 로고
    • Activation of Stat3 sequence-specific DNA binding and transcription by p300/CREB-binding protein-mediated acetylation
    • Wang R, Cherukuri P, Luo J. Activation of Stat3 sequence-specific DNA binding and transcription by p300/CREB-binding protein-mediated acetylation. J Biol Chem 2005;280:11528-34.
    • (2005) J Biol Chem , vol.280 , pp. 11528-11534
    • Wang, R.1    Cherukuri, P.2    Luo, J.3
  • 14
    • 36849012237 scopus 로고    scopus 로고
    • Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas
    • Gao SP, Mark KG, Leslie K, Pao W, Motoi N, Gerald WL, et al. Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. J Clin Invest 2007;117:3846-56.
    • (2007) J Clin Invest , vol.117 , pp. 3846-3856
    • Gao, S.P.1    Mark, K.G.2    Leslie, K.3    Pao, W.4    Motoi, N.5    Gerald, W.L.6
  • 15
    • 34548549283 scopus 로고    scopus 로고
    • Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer
    • Berishaj M, Gao SP, Ahmed S, Leslie K, Al-Ahmadie H, Gerald WL, et al. Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer. Breast Cancer Res 2007;9:R32.
    • (2007) Breast Cancer Res , vol.9 , pp. R32
    • Berishaj, M.1    Gao, S.P.2    Ahmed, S.3    Leslie, K.4    Al-Ahmadie, H.5    Gerald, W.L.6
  • 16
    • 84872229121 scopus 로고    scopus 로고
    • Prognostic significance of B-cells and pSTAT3 in patients with ovarian cancer
    • Yang C, Lee H, Jove V, Deng J, Zhang W, Liu X, et al. Prognostic significance of B-cells and pSTAT3 in patients with ovarian cancer. PLoS ONE 2013;8:e54029.
    • (2013) PLoS ONE , vol.8 , pp. e54029
    • Yang, C.1    Lee, H.2    Jove, V.3    Deng, J.4    Zhang, W.5    Liu, X.6
  • 17
    • 82655189564 scopus 로고    scopus 로고
    • STAT3 is necessary for proliferation and survival in colon cancer-initiating cells
    • Lin L, Liu A, Peng Z, Lin HJ, Li PK, Li C, et al. STAT3 is necessary for proliferation and survival in colon cancer-initiating cells. Cancer Res 2011;71:7226-37.
    • (2011) Cancer Res , vol.71 , pp. 7226-7237
    • Lin, L.1    Liu, A.2    Peng, Z.3    Lin, H.J.4    Li, P.K.5    Li, C.6
  • 18
    • 7444238184 scopus 로고    scopus 로고
    • Novel single-stranded oligonucleotides that inhibit signal transducer and activator of transcription 3 induce apoptosis in vitro and in vivo in prostate cancer cell lines
    • Barton BE, Murphy TF, Shu P, Huang HF, Meyenhofer M, Barton A. Novel single-stranded oligonucleotides that inhibit signal transducer and activator of transcription 3 induce apoptosis in vitro and in vivo in prostate cancer cell lines. Mol Cancer Ther 2004;3:1183-91.
    • (2004) Mol Cancer Ther , vol.3 , pp. 1183-1191
    • Barton, B.E.1    Murphy, T.F.2    Shu, P.3    Huang, H.F.4    Meyenhofer, M.5    Barton, A.6
  • 20
    • 38949165127 scopus 로고    scopus 로고
    • Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas
    • Ding BB, Yu JJ, Yu RY, Mendez LM, Shaknovich R, Zhang Y, et al. Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas. Blood 2008;111:1515-23.
    • (2008) Blood , vol.111 , pp. 1515-1523
    • Ding, B.B.1    Yu, J.J.2    Yu, R.Y.3    Mendez, L.M.4    Shaknovich, R.5    Zhang, Y.6
  • 21
    • 43549097394 scopus 로고    scopus 로고
    • Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma
    • Lam LT, Wright G, Davis RE, Lenz G, Farinha P, Dang L, et al. Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma. Blood 2008;111:3701-13.
    • (2008) Blood , vol.111 , pp. 3701-3713
    • Lam, L.T.1    Wright, G.2    Davis, R.E.3    Lenz, G.4    Farinha, P.5    Dang, L.6
  • 22
    • 84872197104 scopus 로고    scopus 로고
    • High nuclear expression of STAT3 is associated with unfavorable prognosis in diffuse large B-cell lymphoma
    • Wu ZL, Song YQ, Shi YF, Zhu J. High nuclear expression of STAT3 is associated with unfavorable prognosis in diffuse large B-cell lymphoma. J Hematol Oncol 2011;4:31.
    • (2011) J Hematol Oncol , vol.4 , pp. 31
    • Wu, Z.L.1    Song, Y.Q.2    Shi, Y.F.3    Zhu, J.4
  • 23
    • 84869786887 scopus 로고    scopus 로고
    • Expression of Myc, but not pSTAT3, is an adverse prognostic factor for diffuse large B-cell lymphoma treated with epratuzumab/R-CHOP
    • Gupta M, Maurer MJ, Wellik LE, Law ME, Han JJ, Ozsan N, et al. Expression of Myc, but not pSTAT3, is an adverse prognostic factor for diffuse large B-cell lymphoma treated with epratuzumab/R-CHOP. Blood 2012;120:4400-6.
    • (2012) Blood , vol.120 , pp. 4400-4406
    • Gupta, M.1    Maurer, M.J.2    Wellik, L.E.3    Law, M.E.4    Han, J.J.5    Ozsan, N.6
  • 24
    • 84894580544 scopus 로고    scopus 로고
    • Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP
    • Huang X, Meng B, Iqbal J, Ding BB, Perry AM, Cao W, et al. Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP. J Clin Oncol 2013;31:4520-8.
    • (2013) J Clin Oncol , vol.31 , pp. 4520-4528
    • Huang, X.1    Meng, B.2    Iqbal, J.3    Ding, B.B.4    Perry, A.M.5    Cao, W.6
  • 25
    • 84891606259 scopus 로고    scopus 로고
    • MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: A report from the International DLBCL Rituximab-CHOP Consortium Program
    • Xu-Monette ZY, Moller MB, Tzankov A, Montes-Moreno S, Hu W, Manyam GC, et al. MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program. Blood 2013;122:2630-40.
    • (2013) Blood , vol.122 , pp. 2630-2640
    • Xu-Monette, Z.Y.1    Moller, M.B.2    Tzankov, A.3    Montes-Moreno, S.4    Hu, W.5    Manyam, G.C.6
  • 26
    • 84903789487 scopus 로고    scopus 로고
    • Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP
    • Tzankov A, Xu-Monette ZY, Gerhard M, Visco C, Dirnhofer S, Gisin N, et al. Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP. Mod Pathol 2014;27:958-71.
    • (2014) Mod Pathol , vol.27 , pp. 958-971
    • Tzankov, A.1    Xu-Monette, Z.Y.2    Gerhard, M.3    Visco, C.4    Dirnhofer, S.5    Gisin, N.6
  • 27
    • 84868602463 scopus 로고    scopus 로고
    • Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: Report from an International DLBCL Rituximab-CHOP Consortium Program Study
    • Xu-Monette ZY, Wu L, Visco C, Tai YC, Tzankov A, Liu WM, et al. Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study. Blood 2012;120:3986-96.
    • (2012) Blood , vol.120 , pp. 3986-3996
    • Xu-Monette, Z.Y.1    Wu, L.2    Visco, C.3    Tai, Y.C.4    Tzankov, A.5    Liu, W.M.6
  • 29
    • 0037316303 scopus 로고    scopus 로고
    • A comparison of normalization methods for high density oligonucleotide array data based on variance and bias
    • Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003;19:185-93.
    • (2003) Bioinformatics , vol.19 , pp. 185-193
    • Bolstad, B.M.1    Irizarry, R.A.2    Astrand, M.3    Speed, T.P.4
  • 30
    • 84879385620 scopus 로고    scopus 로고
    • MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: A report from The International DLBCL Rituximab-CHOP Consortium Program
    • Hu S, Xu-Monette ZY, Tzankov A, Green T, Wu L, Balasubramanyam A, et al. MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program. Blood 2013;121:4021-31.
    • (2013) Blood , vol.121 , pp. 4021-4031
    • Hu, S.1    Xu-Monette, Z.Y.2    Tzankov, A.3    Green, T.4    Wu, L.5    Balasubramanyam, A.6
  • 31
  • 32
    • 0030292721 scopus 로고    scopus 로고
    • Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in antiapoptosis
    • Fukada T, Hibi M, Yamanaka Y, Takahashi-Tezuka M, Fujitani Y, Yamaguchi T, et al. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in antiapoptosis. Immunity 1996;5:449-60.
    • (1996) Immunity , vol.5 , pp. 449-460
    • Fukada, T.1    Hibi, M.2    Yamanaka, Y.3    Takahashi-Tezuka, M.4    Fujitani, Y.5    Yamaguchi, T.6
  • 33
    • 33750036093 scopus 로고    scopus 로고
    • Structural basis for understanding oncogenic p53 mutations and designing rescue drugs
    • Joerger AC, Ang HC, Fersht AR. Structural basis for understanding oncogenic p53 mutations and designing rescue drugs. Proc Natl Acad Sci U S A 2006;103:15056-61.
    • (2006) Proc Natl Acad Sci U S A , vol.103 , pp. 15056-15061
    • Joerger, A.C.1    Ang, H.C.2    Fersht, A.R.3
  • 34
    • 77549083560 scopus 로고    scopus 로고
    • Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer
    • Grivennikov SI, Karin M. Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev 2010;21:11-9.
    • (2010) Cytokine Growth Factor Rev , vol.21 , pp. 11-19
    • Grivennikov, S.I.1    Karin, M.2
  • 35
    • 33845865825 scopus 로고    scopus 로고
    • Crosstalk between cancer and immune cells: Role of STAT3 in the tumour microenvironment
    • Yu H, Kortylewski M, Pardoll D. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol 2007;7:41-51.
    • (2007) Nat Rev Immunol , vol.7 , pp. 41-51
    • Yu, H.1    Kortylewski, M.2    Pardoll, D.3
  • 36
    • 84891909170 scopus 로고    scopus 로고
    • Gefitinib resistance resulted from STAT3-mediated Akt activation in lung cancer cells
    • Wu K, Chang Q, Lu Y, Qiu P, Chen B, Thakur C, et al. Gefitinib resistance resulted from STAT3-mediated Akt activation in lung cancer cells. Oncotarget 2013;4:2430-8.
    • (2013) Oncotarget , vol.4 , pp. 2430-2438
    • Wu, K.1    Chang, Q.2    Lu, Y.3    Qiu, P.4    Chen, B.5    Thakur, C.6
  • 37
    • 84872227268 scopus 로고    scopus 로고
    • Targeting CD44-STAT3 signaling by Gemini vitamin D analog leads to inhibition of invasion in basal-like breast cancer
    • So JY, Smolarek AK, Salerno DM, Maehr H, Uskokovic M, Liu F, et al. Targeting CD44-STAT3 signaling by Gemini vitamin D analog leads to inhibition of invasion in basal-like breast cancer. PLoS ONE 2013;8:e54020.
    • (2013) PLoS ONE , vol.8 , pp. e54020
    • So, J.Y.1    Smolarek, A.K.2    Salerno, D.M.3    Maehr, H.4    Uskokovic, M.5    Liu, F.6
  • 38
    • 80052476422 scopus 로고    scopus 로고
    • Expression of CDK5/p35 in resected patients with non-small cell lung cancer: Relation to prognosis
    • Liu JL, Wang XY, Huang BX, Zhu F, Zhang RG, Wu G. Expression of CDK5/p35 in resected patients with non-small cell lung cancer: relation to prognosis. Med Oncol 2011;28:673-8.
    • (2011) Med Oncol , vol.28 , pp. 673-678
    • Liu, J.L.1    Wang, X.Y.2    Huang, B.X.3    Zhu, F.4    Zhang, R.G.5    Wu, G.6
  • 39
    • 77649305748 scopus 로고    scopus 로고
    • pY-STAT3 and p53 expression predict outcome for poor prognosis diffuse large B-cell lymphoma treated with high dose chemotherapy and autologous stem cell transplantation
    • Stewart DA, Bahlis N, Mansoor A. pY-STAT3 and p53 expression predict outcome for poor prognosis diffuse large B-cell lymphoma treated with high dose chemotherapy and autologous stem cell transplantation. Leuk Lymphoma 2009;50:1276-82.
    • (2009) Leuk Lymphoma , vol.50 , pp. 1276-1282
    • Stewart, D.A.1    Bahlis, N.2    Mansoor, A.3
  • 40
    • 61349087903 scopus 로고    scopus 로고
    • Recurrent numerical aberrations of JAK2 and deregulation of the JAK2-STAT cascade in lymphomas
    • Meier C, Hoeller S, Bourgau C, Hirschmann P, Schwaller J, Went P, et al. Recurrent numerical aberrations of JAK2 and deregulation of the JAK2-STAT cascade in lymphomas. Mod Pathol 2009;22:476-87.
    • (2009) Mod Pathol , vol.22 , pp. 476-487
    • Meier, C.1    Hoeller, S.2    Bourgau, C.3    Hirschmann, P.4    Schwaller, J.5    Went, P.6
  • 41
    • 84884944145 scopus 로고    scopus 로고
    • MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
    • Valera A, Lopez-Guillermo A, Cardesa-Salzmann T, Climent F, Gonzalez-Barca E, Mercadal S, et al. MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Haematologica 2013;98:1554-62.
    • (2013) Haematologica , vol.98 , pp. 1554-1562
    • Valera, A.1    Lopez-Guillermo, A.2    Cardesa-Salzmann, T.3    Climent, F.4    Gonzalez-Barca, E.5    Mercadal, S.6
  • 42
    • 0037474270 scopus 로고    scopus 로고
    • Opposite regulation of myc and p21waf1 transcription by STAT3 proteins
    • Barre B, Avril S, Coqueret O. Opposite regulation of myc and p21waf1 transcription by STAT3 proteins. J Biol Chem 2003;278:2990-6.
    • (2003) J Biol Chem , vol.278 , pp. 2990-2996
    • Barre, B.1    Avril, S.2    Coqueret, O.3
  • 44
    • 63249092765 scopus 로고    scopus 로고
    • Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors
    • Lee H, Herrmann A, Deng JH, Kujawski M, Niu G, Li Z, et al. Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors. Cancer Cell 2009;15:283-93.
    • (2009) Cancer Cell , vol.15 , pp. 283-293
    • Lee, H.1    Herrmann, A.2    Deng, J.H.3    Kujawski, M.4    Niu, G.5    Li, Z.6
  • 45
    • 34249868449 scopus 로고    scopus 로고
    • Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB
    • Yang J, Liao X, Agarwal MK, Barnes L, Auron PE, Stark GR. Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. Genes Dev 2007;21:1396-408.
    • (2007) Genes Dev , vol.21 , pp. 1396-1408
    • Yang, J.1    Liao, X.2    Agarwal, M.K.3    Barnes, L.4    Auron, P.E.5    Stark, G.R.6
  • 46
    • 84862019471 scopus 로고    scopus 로고
    • Regulation of STAT3 by histone deacetylase-3 in diffuse large B-cell lymphoma: Implications for therapy
    • Gupta M, Han JJ, Stenson M, Wellik L, Witzig TE. Regulation of STAT3 by histone deacetylase-3 in diffuse large B-cell lymphoma: implications for therapy. Leukemia 2012;26:1356-64.
    • (2012) Leukemia , vol.26 , pp. 1356-1364
    • Gupta, M.1    Han, J.J.2    Stenson, M.3    Wellik, L.4    Witzig, T.E.5
  • 47
    • 30444431914 scopus 로고    scopus 로고
    • NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation
    • Williams SA, Chen LF, Kwon H, Ruiz-Jarabo CM, Verdin E, Greene WC. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J 2006;25:139-49.
    • (2006) EMBO J , vol.25 , pp. 139-149
    • Williams, S.A.1    Chen, L.F.2    Kwon, H.3    Ruiz-Jarabo, C.M.4    Verdin, E.5    Greene, W.C.6
  • 48
    • 84890606231 scopus 로고    scopus 로고
    • Phase I study of panobinostat plus everolimus in patients with relapsed or refractory lymphoma
    • Oki Y, Buglio D, Fanale M, Fayad L, Copeland A, Romaguera J, et al. Phase I study of panobinostat plus everolimus in patients with relapsed or refractory lymphoma. Clin Cancer Res 2013;19:6882-90.
    • (2013) Clin Cancer Res , vol.19 , pp. 6882-6890
    • Oki, Y.1    Buglio, D.2    Fanale, M.3    Fayad, L.4    Copeland, A.5    Romaguera, J.6
  • 49
    • 79955485953 scopus 로고    scopus 로고
    • STAT3 inhibition is a therapeutic strategy for ABC-like diffuse large B-cell lymphoma
    • Scuto A, Kujawski M, Kowolik C, Krymskaya L, Wang L, Weiss LM, et al. STAT3 inhibition is a therapeutic strategy for ABC-like diffuse large B-cell lymphoma. Cancer Res 2011;71:3182-8.
    • (2011) Cancer Res , vol.71 , pp. 3182-3188
    • Scuto, A.1    Kujawski, M.2    Kowolik, C.3    Krymskaya, L.4    Wang, L.5    Weiss, L.M.6
  • 50
    • 0034284050 scopus 로고    scopus 로고
    • Prognostic significance of survivin expression in diffuse large B-cell lymphomas
    • Adida C, Haioun C, Gaulard P, Lepage E, Morel P, Briere J, et al. Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood 2000;96:1921-5.
    • (2000) Blood , vol.96 , pp. 1921-1925
    • Adida, C.1    Haioun, C.2    Gaulard, P.3    Lepage, E.4    Morel, P.5    Briere, J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.